Anoro Ellipta (umeclidinium/vilanterol)

pCPA File Number: 20841

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Obstructive Pulmonary Disease (COPD)

Sponsor/Manufacturer:

GlaxoSmithKline Inc.

CDA-AMC Project Number:

SR0371-000

pCPA Engagement Letter Issued:

2015-02-04

Negotiation Process Concluded:

2015-05-01